ABOS
#3693
Acumen Pharmaceuticals, Inc. - Common Stock
2.0 2 USD
-0.06%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-5.61%
Variación mensual
-30.58%
Variación en los últimos 6 meses
-21.09%
Cambio anual
-2.88%
Cierres anteriores
2.1 4
Open
2.1 4
Mínimo
2.0 0
Máximo
2.1 4
Financials
- Market Capitalization 146.08 M
- Employee 61
- Founded 1996
- CEO N/A
- Website www.acumenpharm.com
- Headquarter Delaware, United States
- FIGI BBG0058YJ317
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.05
Relación precio/flujo de caja
638.93
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3674 |  MOLN Molecular Partners AG - American Depositary Shares | 3.79 USD | -1.56% | -7.79% | -8.67% | +1.88% | 153.02 M USD | ||
| 3677 |  NBP NovaBridge Biosciences - American Depositary Shares | 1.32 USD | -5.71% | -4.35% | -16.98% | -70.73% | 152.30 M USD | ||
| 3702 |  OTLK Outlook Therapeutics, Inc. - Common Stock | 0.59 USD | -1.67% | -1.67% | -9.23% | +43.03% | 143.63 M USD | ||
| 3710 |  RNA Atrium Therapeutics, Inc. - Common Stock | 8.21 USD | -2.26% | +2.63% | -20.83% | -88.33% | 140.44 M USD |